Skip to content
Global markets · Independent coverage Follow a hub and receive new coverage by email.
TechStock2Market intelligence
Signalbook

NYSE:CANF

Can-Fite BioPharma (NYSEAMERICAN:CANF) jumps after Japan patent update

Can-Fite BioPharma Ltd. rallied in premarket trading Friday after reporting a Japanese patent allowance for Namodenoson targeting obesity. The move was strong but volume stood out as cleaner signal, with a late MarketWatch quote…

3 min read
NYSE:CANFStock Market

Company hubNYSE:CANF

Can-Fite BioPharma (NYSEAMERICAN:CANF) (CANF) Stock News & Analysis

Follow the latest Can-Fite BioPharma (NYSEAMERICAN:CANF) (CANF) company news, earnings coverage and investor analysis from TechStock².

Save this hub to your TS2 Signalbook account.
Latest update
Articles in this hub
2
Last 30 days
0

What investors are watching

  • Earnings, guidance and financial performance
  • Valuation, trading activity and market sentiment
  • Strategy, catalysts and company-specific risks
Read latest coveragePrefer TechStock² in Google

All coverage

NYSE:CANF

2 articles